1. Home
  2. DOGZ vs BDTX Comparison

DOGZ vs BDTX Comparison

Compare DOGZ & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DOGZ

Dogness (International) Corporation

HOLD

Current Price

$1.53

Market Cap

153.5M

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOGZ
BDTX
Founded
2003
2014
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
116.8M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
DOGZ
BDTX
Price
$1.53
$2.24
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$9.25
AVG Volume (30 Days)
150.8K
584.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
130.71
EPS
N/A
0.39
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.37
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.20
52 Week High
$34.53
$4.94

Technical Indicators

Market Signals
Indicator
DOGZ
BDTX
Relative Strength Index (RSI) 28.30 46.98
Support Level $1.36 $2.19
Resistance Level $1.71 $2.67
Average True Range (ATR) 0.12 0.14
MACD 0.23 -0.00
Stochastic Oscillator 39.74 47.01

Price Performance

Historical Comparison
DOGZ
BDTX

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: